Expertise in
16
conditions

Dr. William M. Schnitz

Rheumatology
Sestak Rheumatology
3555 NW 58th St Ste 804, 
Oklahoma City, OK 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
16
conditions
Sestak Rheumatology
3555 NW 58th St Ste 804, 
Oklahoma City, OK 

Overview

William Schnitz is a Rheumatologist practicing medicine in Oklahoma City, Oklahoma.

Dr. Schnitz is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Microscopic Polyangiitis, Necrotizing Vasculitis, and Felty Syndrome.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Schnitz is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in OK

Hospital Affiliations

Onecore Health
Integris Baptist Medical Center, Inc
Grady Memorial Hospital
Stillwater Medical Center
O U Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
GlobalHealth
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Sestak Rheumatology
3555 NW 58th St Ste 804, Oklahoma City, OK 73112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
View 4 Less Clinical Trials

1 Total Publications

Tophaceous gout with rare involvement of the patella.
Tophaceous gout with rare involvement of the patella.
Journal: Radiology case reports
Published: May 29, 2016
Similar Doctors
Expertise in
6
conditions
Dr. Ira N. Targoff
Rheumatology
Expertise in
6
conditions
Dr. Ira N. Targoff
Rheumatology
Referral may be required
Before you request

Ou Health Physicians-Internal Medicine Clinic

1000 NE 13th St # 1G, 
Oklahoma City, OK 
 (5.0 miles away)
572-244-0063
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ira Targoff is a Rheumatologist practicing medicine in Oklahoma City, Oklahoma. Dr. Targoff is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Juvenile Dermatomyositis, Polymyositis, and Myositis. Dr. Targoff is currently accepting new patients.

Expertise in
20
conditions
Dr. Craig W. Carson
Rheumatology
Expertise in
20
conditions
Dr. Craig W. Carson
Rheumatology
Referral may be required

Oklahoma Arthritis Center PC

1701 Renaissance Blvd Ste 110, 
Edmond, OK 
 (8.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Craig Carson is a Rheumatologist practicing medicine in Edmond, Oklahoma. Dr. Carson is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Carson is currently accepting new patients.

Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required

Oklahoma Medical Research Foundation

825 N.E. 13th St., 
Oklahoma City, OK 
 (5.0 miles away)
405-271-6242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Board certified in internal medicine and rheumatology, Cristina Arriens, MD serves SSM Health St. Anthony patients in the Oklahoma City metro area at the Oklahoma Medical Research Foundation. As a rheumatologist, she specializes in conditions such as arthritis and autoimmune diseases, among others. She has participated in extensive research in arthritis and clinical immunology, including but not limited to research on systemic lupus erythematosus and various potential treatments. Dr. Arriens is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Arthritis, and Rheumatoid Arthritis (RA). Dr. Arriens is board certified in American Board Of Internal Medicine/Rheumatology , Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Arriens is currently accepting new patients.

Frequently Asked Questions about Dr. William M. Schnitz

How do I make an appointment with Dr. William M. Schnitz?

You can book an appointment with Dr. William M. Schnitz by calling their office at 405-548-0430. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William M. Schnitz a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William M. Schnitz is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William M. Schnitz specialize in?

While Dr. William M. Schnitz is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Microscopic Polyangiitis, and Necrotizing Vasculitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. William M. Schnitz participate in research or clinical trials?

Yes. Dr. William M. Schnitz has published 1 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. William M. Schnitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. William M. Schnitz accept my insurance?

Dr. William M. Schnitz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 405-548-0430 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schnitz's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile